These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3750371)

  • 1. Hemodialysis clearance of chloroquine in uremic patients.
    Akintonwa A; Odutola TA; Edeki T; Mabadeje AF
    Ther Drug Monit; 1986; 8(3):285-7. PubMed ID: 3750371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis of acetaminophen in uremic patients.
    Marbury TC; Wang LH; Lee CS
    Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
    Wang LH; Lee CS; Majeske BL; Marbury TC
    Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
    Lee CS; Marbury TC; Benet LZ
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
    Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
    Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
    Zhang ZH; Mao JR; Chen H; Su W; Zhang Y; Zhang L; Chen DQ; Zhao YY; Vaziri ND
    Clin Biochem; 2017 Dec; 50(18):1078-1086. PubMed ID: 28928007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
    Lee CS; Wang LH; Marbury TC; Bruni J; Perchalski RJ
    Clin Toxicol; 1980 Oct; 17(3):429-38. PubMed ID: 7449356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis of theophylline in uremic patients.
    Lee CS; Marbury TC; Perrin JH; Fuller TJ
    J Clin Pharmacol; 1979 Apr; 19(4):219-26. PubMed ID: 438357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of primidone elimination by uremic patients.
    Lee CS; Marbury TC; Perchalski RT; Wilder BJ
    J Clin Pharmacol; 1982 Jul; 22(7):301-8. PubMed ID: 7107978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis clearance of total and unbound lidocaine.
    Jacobi J; McGory RW; McCoy H; Matzke GR
    Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis of mefenamic acid in uremic patients.
    Wang LH; Lee CS; Marbury TC
    Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites.
    Antal EJ; Wright CE; Brown BL; Albert KS; Aman LC; Levin NW
    J Clin Pharmacol; 1986 Mar; 26(3):184-90. PubMed ID: 3958223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
    Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
    Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of end-stage renal disease and dialysis modalities on blood ammonia level.
    Vaziri ND; Khazaeli M; Nunes ACF; Harley KT; Said H; Alipour O; Lau WL; Pahl MV
    Hemodial Int; 2017 Jul; 21(3):343-347. PubMed ID: 27804262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide method for evaluating the performance of hemodialysis in vivo.
    Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
    Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.